Histocompatibility Minor 13 (HM13), targeted by miR-760, exerts oncogenic role in breast cancer by suppressing autophagy and activating PI3K-AKT-mTOR pathway

Histocompatibility Minor 13 (HM13) is reported to participate in regulating multiple cancers. In the present study, we uncovered that HM13 was highly expressed in breast cancer and correlated with worse prognosis. Downregulation of HM13 could suppress breast cancer cell proliferation and metastasis...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Haiyan, Li, Zhi, Wang, Zhangwei, Zhang, Xu, Dai, Xinyuan, Zhou, Guoren, Ding, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509374/
https://www.ncbi.nlm.nih.gov/pubmed/36153332
http://dx.doi.org/10.1038/s41419-022-05154-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509374/
https://www.ncbi.nlm.nih.gov/pubmed/36153332
http://dx.doi.org/10.1038/s41419-022-05154-4

Ejemplares similares